JNGLX vs. FBTTX
Compare and contrast key facts about Janus Henderson Global Life Sciences Fund (JNGLX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX).
JNGLX is managed by Janus Henderson. It was launched on Dec 30, 1998. FBTTX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
JNGLX vs. FBTTX - Performance Comparison
Loading graphics...
JNGLX vs. FBTTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JNGLX Janus Henderson Global Life Sciences Fund | -3.73% | 24.84% | 3.60% | 7.51% | -2.69% | 6.78% | 25.66% | 29.20% | 4.17% | 22.13% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 2.18% | 39.21% | 5.08% | 10.43% | -8.22% | -3.35% | 31.82% | 25.39% | -4.19% | 25.37% |
Returns By Period
In the year-to-date period, JNGLX achieves a -3.73% return, which is significantly lower than FBTTX's 2.18% return. Both investments have delivered pretty close results over the past 10 years, with JNGLX having a 11.02% annualized return and FBTTX not far ahead at 11.54%.
JNGLX
- 1D
- 3.08%
- 1M
- -5.55%
- YTD
- -3.73%
- 6M
- 11.88%
- 1Y
- 21.71%
- 3Y*
- 10.69%
- 5Y*
- 7.33%
- 10Y*
- 11.02%
FBTTX
- 1D
- 5.09%
- 1M
- -0.77%
- YTD
- 2.18%
- 6M
- 15.39%
- 1Y
- 55.03%
- 3Y*
- 20.14%
- 5Y*
- 8.63%
- 10Y*
- 11.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
JNGLX vs. FBTTX - Expense Ratio Comparison
JNGLX has a 0.80% expense ratio, which is lower than FBTTX's 1.28% expense ratio.
Return for Risk
JNGLX vs. FBTTX — Risk / Return Rank
JNGLX
FBTTX
JNGLX vs. FBTTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janus Henderson Global Life Sciences Fund (JNGLX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JNGLX | FBTTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.07 | 1.92 | -0.85 |
Sortino ratioReturn per unit of downside risk | 1.54 | 2.52 | -0.98 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.32 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | 1.80 | 3.13 | -1.33 |
Martin ratioReturn relative to average drawdown | 4.97 | 12.48 | -7.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| JNGLX | FBTTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.07 | 1.92 | -0.85 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.47 | 0.37 | +0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.63 | 0.47 | +0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.57 | 0.30 | +0.27 |
Correlation
The correlation between JNGLX and FBTTX is 0.88, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
JNGLX vs. FBTTX - Dividend Comparison
JNGLX's dividend yield for the trailing twelve months is around 4.74%, more than FBTTX's 1.50% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNGLX Janus Henderson Global Life Sciences Fund | 4.74% | 4.56% | 5.84% | 4.26% | 0.25% | 9.85% | 7.80% | 6.23% | 13.32% | 0.89% | 0.30% | 8.81% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 1.50% | 1.53% | 6.41% | 0.93% | 0.00% | 21.60% | 8.79% | 7.10% | 2.64% | 0.00% | 0.00% | 5.42% |
Drawdowns
JNGLX vs. FBTTX - Drawdown Comparison
The maximum JNGLX drawdown since its inception was -59.00%, smaller than the maximum FBTTX drawdown of -63.75%. Use the drawdown chart below to compare losses from any high point for JNGLX and FBTTX.
Loading graphics...
Drawdown Indicators
| JNGLX | FBTTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.00% | -63.75% | +4.75% |
Max Drawdown (1Y)Largest decline over 1 year | -9.68% | -13.58% | +3.90% |
Max Drawdown (5Y)Largest decline over 5 years | -22.21% | -36.64% | +14.43% |
Max Drawdown (10Y)Largest decline over 10 years | -27.37% | -39.04% | +11.67% |
Current DrawdownCurrent decline from peak | -6.62% | -2.61% | -4.01% |
Average DrawdownAverage peak-to-trough decline | -17.73% | -21.95% | +4.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.61% | 3.72% | -0.11% |
Volatility
JNGLX vs. FBTTX - Volatility Comparison
The current volatility for Janus Henderson Global Life Sciences Fund (JNGLX) is 5.98%, while Fidelity Advisor Biotechnology Fund Class M (FBTTX) has a volatility of 9.37%. This indicates that JNGLX experiences smaller price fluctuations and is considered to be less risky than FBTTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| JNGLX | FBTTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.98% | 9.37% | -3.39% |
Volatility (6M)Calculated over the trailing 6-month period | 10.63% | 17.02% | -6.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.86% | 25.99% | -8.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.69% | 23.31% | -7.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.42% | 24.58% | -7.16% |